UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The development and manufacture of influenza vaccines

Human vaccines & immunotherapeutics, 2015-06, Vol.11 (6), p.1357-1360

Buckland, Barry C

2015

Volltextzugriff (PDF)

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine, 2014-09, Vol.32 (42), p.5496-5502

2014

Volltextzugriff (PDF)

The process development challenge for a new vaccine

Nature medicine, 2005-04, Vol.11 (4 Suppl), p.S16-S19

Buckland, Barry C

2005

Volltextzugriff (PDF)

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Biotechnology and bioengineering, 2015-11, Vol.112 (11), p.2267-2275

2015

Volltextzugriff (PDF)

Vaccine Technology V: The art of taking vaccines to disease prevention

Vaccine, 2015-08, Vol.33 (35), p.4219-4220

2015

Volltextzugriff (PDF)

Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010

Vaccine, 2011-09, Vol.29 (41), p.7115-7116

2011

Volltextzugriff (PDF)

Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process

Biotechnology and bioengineering, 2003-06, Vol.82 (6), p.640-652

2003

Volltextzugriff (PDF)

Vaccine process technology

Biotechnology and bioengineering, 2012-06, Vol.109 (6), p.1443-1460

2012

Volltextzugriff (PDF)

Fractional precipitation of plasmid DNA from lysate by CTAB

Biotechnology and bioengineering, 2002-09, Vol.79 (7), p.776-784

2002

Volltextzugriff (PDF)

Metabolic engineering and directed evolution for the production of pharmaceuticals

Current Opinion in Biotechnology, 2000-04, Vol.11 (2), p.209-214

2000

Volltextzugriff (PDF)

Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine

Current opinion in chemical biology, 2016-06, Vol.32, p.34-47

2016

Volltextzugriff (PDF)

Vaccine process technology—A decade of progress

Biotechnology and bioengineering, 2024-09, Vol.121 (9), p.2604-2635

2024

Volltextzugriff (PDF)

Asymmetric bioreductions: application to the synthesis of pharmaceuticals

Journal of molecular catalysis. B, Enzymatic, 2001-01, Vol.11 (4-6), p.503-512

2001

Volltextzugriff (PDF)

Vaccine Technology IV: An ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012

Vaccine, 2014-05, Vol.32 (24), p.2763-2766

2014

Volltextzugriff (PDF)

Monoclonal Antibody Process Development Using Medium Concentrates

Biotechnology progress, 1994-01, Vol.10 (1), p.87-96

1994

Volltextzugriff (PDF)

Technology transfer and scale-up of the Flublok registered recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine, 2014-09, Vol.32 (42), p.5496-5502

2014

Volltextzugriff (PDF)

Mechanism of a Decrease in Potency for the Recombinant Influenza A Virus Hemagglutinin H3 Antigen During Storage

Journal of pharmaceutical sciences, 2014-03, Vol.103 (3), p.821-827

2014

Volltextzugriff (PDF)

Vaccine Technology IV, Albufeira, Portugal 20-24 May 2012

Vaccine, 2014, Vol.32 (24)

2014

Volltextzugriff (PDF)

Asymmetric bioreduction of (2-(4-nitro-phenyl) -N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [( R) -N- (2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide] by using Candida sorbophila MY 1833

Enzyme and microbial technology, 1999-09, Vol.25 (6), p.489-496

1999

Volltextzugriff (PDF)

Pilot-scale harvest of recombinant yeast employing microfiltration: a case study

Journal of biotechnology, 1995-10, Vol.42 (3), p.235-246

1995

Volltextzugriff (PDF)

Microbial Conversion of Indene to Indandiol: A Key Intermediate in the Synthesis of CRIXIVAN

Metabolic engineering, 1999-01, Vol.1 (1), p.63-74

1999

Volltextzugriff (PDF)

Introduction

Vaccine, 2009-10, Vol.27 (46), p.6393

2009

Volltextzugriff (PDF)

Introduction

Vaccine, 2009-10, Vol.27 (46), p.6393

2009

Volltextzugriff (PDF)

Introduction

Vaccine, 2009, Vol.27 (46), p.6393-6393

2009

Volltextzugriff (PDF)

Fed-batch culture of recombinant NSO myeloma cells with high monoclonal antibody production

Biotechnology and bioengineering, 1997-09, Vol.55 (5), p.783-792

1997

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Biotechnology & Applied Microbiology
(26)
Biological And Medical Sciences
(21)
Fundamental And Applied Biological Sciences. Psychology
(18)
Biotechnology
(17)
Humans
(14)
Methods. Procedures. Technologies
(14)
Animals
(11)
Vaccines
(9)
Bioreactors
(6)
Fermentation
(6)
Immunology
(6)
Allergy And Immunology
(5)
Cell Culture
(5)
Influenza
(5)
Medicine, Research & Experimental
(5)
Microbiology
(5)
Research & Experimental Medicine
(5)
Animal Cells
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The development and manufacture of influenza vaccines

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

The process development challenge for a new vaccine

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Vaccine Technology V: The art of taking vaccines to disease prevention

Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010

Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process

Vaccine process technology

Fractional precipitation of plasmid DNA from lysate by CTAB

Metabolic engineering and directed evolution for the production of pharmaceuticals

Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine

Vaccine process technology—A decade of progress

Asymmetric bioreductions: application to the synthesis of pharmaceuticals

Vaccine Technology IV: An ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012

Monoclonal Antibody Process Development Using Medium Concentrates

Technology transfer and scale-up of the Flublok registered recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Mechanism of a Decrease in Potency for the Recombinant Influenza A Virus Hemagglutinin H3 Antigen During Storage

Vaccine Technology IV, Albufeira, Portugal 20-24 May 2012

Asymmetric bioreduction of (2-(4-nitro-phenyl) -N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [( R) -N- (2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide] by using Candida sorbophila MY 1833

Pilot-scale harvest of recombinant yeast employing microfiltration: a case study

Microbial Conversion of Indene to Indandiol: A Key Intermediate in the Synthesis of CRIXIVAN

Introduction

Introduction

Introduction

Fed-batch culture of recombinant NSO myeloma cells with high monoclonal antibody production

Suchergebnisse filtern